Cargando…
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
BACKGROUND: Whether olanzapine/fluoxetine combination (OFC) is superior to olanzapine or fluoxetine monotherapy in patients with treatment-resistant depression (TRD) remains controversial. Thus, we conducted this meta-analysis of randomized controlled trials (RCTs) to compare the efficacy and safety...
Autores principales: | Luan, Shuxin, Wan, Hongquan, Wang, Shijun, Li, He, Zhang, Baogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338977/ https://www.ncbi.nlm.nih.gov/pubmed/28280343 http://dx.doi.org/10.2147/NDT.S127453 |
Ejemplares similares
-
Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
por: Brunner, Elizabeth, et al.
Publicado: (2014) -
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
por: Bobo, William V, et al.
Publicado: (2009) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan, Shuxin, et al.
Publicado: (2018) -
Olanzapine and fluoxetine combination in severe or resistant depression
por: Haridas, R.M., et al.
Publicado: (2003) -
Weight loss dynamics during combined fluoxetine and olanzapine treatment
por: Perrone, Jennifer A, et al.
Publicado: (2004)